Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C48H65N15O9 |
| Molecular Weight | 996.1248 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CCC(=O)NC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CNC=N3)NC1=O)C(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(N)=O
InChI
InChIKey=KPDWCDURFGPKLY-PDBPWWFNSA-N
InChI=1S/C48H65N15O9/c1-3-4-14-33(57-27(2)64)42(67)59-35-17-18-40(65)55-25-39(47(72)60-36(41(49)66)21-29-23-54-32-15-9-8-13-31(29)32)63-43(68)34(16-10-19-53-48(50)51)58-45(70)37(20-28-11-6-5-7-12-28)61-46(71)38(62-44(35)69)22-30-24-52-26-56-30/h5-9,11-13,15,23-24,26,33-39,54H,3-4,10,14,16-22,25H2,1-2H3,(H2,49,66)(H,52,56)(H,55,65)(H,57,64)(H,58,70)(H,59,67)(H,60,72)(H,61,71)(H,62,69)(H,63,68)(H4,50,51,53)/t33-,34-,35-,36-,37+,38-,39-/m0/s1
| Molecular Formula | C48H65N15O9 |
| Molecular Weight | 996.1248 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:33:21 GMT 2025
by
admin
on
Mon Mar 31 22:33:21 GMT 2025
|
| Record UNII |
16134B0YTH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
670418
Created by
admin on Mon Mar 31 22:33:21 GMT 2025 , Edited by admin on Mon Mar 31 22:33:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
88944400
Created by
admin on Mon Mar 31 22:33:21 GMT 2025 , Edited by admin on Mon Mar 31 22:33:21 GMT 2025
|
PRIMARY | |||
|
16134B0YTH
Created by
admin on Mon Mar 31 22:33:21 GMT 2025 , Edited by admin on Mon Mar 31 22:33:21 GMT 2025
|
PRIMARY | |||
|
1309111-58-7
Created by
admin on Mon Mar 31 22:33:21 GMT 2025 , Edited by admin on Mon Mar 31 22:33:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
OFF-TARGET->NON-AGONIST |
EC50
|
||
|
OFF TARGET->NON-INHIBITOR |
IC50
|
||
|
|
OFF TARGET->WEAK AGONIST |
EC50
|
||
|
|
OFF-TARGET->AGONIST |
Emax 87 at 10 micromolar
EC50
|
||
|
TARGET -> AGONIST |
BINDING
IC50
|
||
|
|
OFF-TARGET->NON-AGONIST |
EC50
|
||
|
TARGET -> AGONIST |
Inhibition of activation of the nuclear transcription factor NF-?B.
EC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Potential Therapy for Gastrointestinal (GI) Inflammatory Diseases
|
